HLB opened an office in the U.S. city of Cambridge, Massachusetts, to strengthen collaborations with global pharmaceutical companies and support the overseas market entry of its group companies, the Korean biotech said Thursday.
Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
<p>Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the <a href="https://www.hopkinsmedicine.org/kimmel-cancer-center">Johns Hopkins Kimmel Cancer Center</a> and its <a href="https://www.hopkinsmedicine.org/kimmel-cancer-center/bloomberg-kimmel-institute-for-cancer-immunotherapy">Bloomberg~Kimmel Institute for Cancer Immunotherapy</a><u>.</u></p>
Immune cell receptor provides promising immunotherapy target medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Glioma Clinical Trial Pipeline Insights | 200+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.